Acetylsalicylic Acid Plus Intensive Blood Pressure Treatment in Patients With Unruptured Intracranial Aneurysms
Status:
Recruiting
Trial end date:
2022-10-01
Target enrollment:
Participant gender:
Summary
Purpose of this study is to assess the hypothesis that a strategy with acetylsalicylic acid
(ASA) 100 mg/day, intensive blood pressure treatment (targeted systolic blood pressure below
120 mmHg), and a blood pressure measuring device reduces the risk of aneurysm rupture or
growth compared with standard care (i.e. no ASA, blood pressure management according to
standard blood pressure management, no blood pressure measuring device)
Phase:
Phase 3
Details
Lead Sponsor:
Universitätsmedizin Mannheim
Collaborators:
KKS Netzwerk Schwiete Stiftung, Mannheim, Germany UMC Utrecht University of Hamburg University of Hamburg-Eppendorf